Utrecht Health Seed Fund

Phlox Therapeutics focuses on developing gene therapies aimed at alleviating and curing various forms of cardiomyopathy and other heart diseases. The company employs innovative technologies, including RNA-based therapeutics and other cardiac solutions, to provide patients with lasting benefits. By targeting the underlying genetic mutations responsible for these conditions, Phlox Therapeutics aims to improve patient outcomes and offer effective treatment options for genetic heart diseases.

Synerkine Pharma is engaged in the development of novel fusion proteins aimed at treating inflammatory, neuropathic, and osteoarthritic pain. The company's innovative protein targets key regulatory mechanisms associated with various forms of chronic pain, offering unique properties that help normalize pain and inhibit inflammation. This approach enables patients to access effective pharmaceutical solutions designed to reduce pain across multiple pre-clinical models.

Cordys Analytics focuses on detecting heart illness via electrocardiograms (ECGs) using AI-powered algorithms. It aims to transform cardiac care by offering doctors easy access to AI diagnoses for electrocardiograms (ECGs).

Moveshelf is a cloud-based software application designed for professionals working with 3D motion data, including character animators, motion capture technicians, and movement scientists. It provides a secure platform for storing, organizing, analyzing, and collaborating on 3D data via any modern browser, making it accessible on smartphones, tablets, and computers. The application supports all major motion capture systems and various 3D motion data file formats, allowing users to share animated characters and interactive reports effortlessly. Moveshelf facilitates collaboration by enabling users to create and send comprehensive gait and movement analysis reports through a simple link. The platform also features open source APIs in multiple programming languages, integrating seamlessly with popular tools like Unity, Unreal, and MATLAB. Founded by experts in motion tracking, Moveshelf aims to enhance the understanding and utility of digital human motion data to empower professionals in their work.

TargED Biopharmaceuticals is a biotechnology company focused on developing innovative biological drugs aimed at enhancing the treatment of thrombosis. The company utilizes small antibodies, known as VhH, to deliver enzymes directly to the sites of thrombus, facilitating targeted thrombolysis. This approach allows for effective treatment regardless of the blood clot's composition, thereby enabling healthcare professionals to accelerate patient care and improve outcomes for those affected by thrombosis.

Moveshelf is a cloud-based software application designed for professionals working with 3D motion data, including character animators, motion capture technicians, and movement scientists. It provides a secure platform for storing, organizing, analyzing, and collaborating on 3D data via any modern browser, making it accessible on smartphones, tablets, and computers. The application supports all major motion capture systems and various 3D motion data file formats, allowing users to share animated characters and interactive reports effortlessly. Moveshelf facilitates collaboration by enabling users to create and send comprehensive gait and movement analysis reports through a simple link. The platform also features open source APIs in multiple programming languages, integrating seamlessly with popular tools like Unity, Unreal, and MATLAB. Founded by experts in motion tracking, Moveshelf aims to enhance the understanding and utility of digital human motion data to empower professionals in their work.

TargED Biopharmaceuticals is a biotechnology company focused on developing innovative biological drugs aimed at enhancing the treatment of thrombosis. The company utilizes small antibodies, known as VhH, to deliver enzymes directly to the sites of thrombus, facilitating targeted thrombolysis. This approach allows for effective treatment regardless of the blood clot's composition, thereby enabling healthcare professionals to accelerate patient care and improve outcomes for those affected by thrombosis.